ATE275940T1 - Medizinische aerosolformulierungen von formoterol - Google Patents

Medizinische aerosolformulierungen von formoterol

Info

Publication number
ATE275940T1
ATE275940T1 AT97929756T AT97929756T ATE275940T1 AT E275940 T1 ATE275940 T1 AT E275940T1 AT 97929756 T AT97929756 T AT 97929756T AT 97929756 T AT97929756 T AT 97929756T AT E275940 T1 ATE275940 T1 AT E275940T1
Authority
AT
Austria
Prior art keywords
formoterol
aerosol formulations
medical aerosol
medical
formulations
Prior art date
Application number
AT97929756T
Other languages
English (en)
Inventor
Martin J Oliver
Simon G Paling
Philip A Jinks
Sukhbinder K Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE275940(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Application granted granted Critical
Publication of ATE275940T1 publication Critical patent/ATE275940T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97929756T 1996-06-11 1997-06-02 Medizinische aerosolformulierungen von formoterol ATE275940T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations
PCT/US1997/009471 WO1997047286A1 (en) 1996-06-11 1997-06-02 Medicinal aerosol formulations of formoterol

Publications (1)

Publication Number Publication Date
ATE275940T1 true ATE275940T1 (de) 2004-10-15

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97929756T ATE275940T1 (de) 1996-06-11 1997-06-02 Medizinische aerosolformulierungen von formoterol

Country Status (16)

Country Link
EP (2) EP0934057B1 (de)
JP (1) JP5000793B2 (de)
AR (1) AR009231A1 (de)
AT (1) ATE275940T1 (de)
AU (1) AU726382B2 (de)
CA (1) CA2257841C (de)
DE (1) DE69730723T2 (de)
DK (1) DK0934057T3 (de)
ES (1) ES2229366T3 (de)
GB (1) GB9612297D0 (de)
ID (1) ID19520A (de)
NO (1) NO320403B1 (de)
NZ (1) NZ333202A (de)
PT (1) PT934057E (de)
WO (1) WO1997047286A1 (de)
ZA (1) ZA974546B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
ES2178479T3 (es) * 1998-10-17 2002-12-16 Boehringer Ingelheim Pharma Concentrado de principio activo con formoterol, apto para el almacenamiento.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1273292B1 (de) 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1878664B1 (de) * 2002-08-27 2011-03-30 Schering Corporation Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
US8435497B2 (en) 2003-06-13 2013-05-07 Takeda Gmbh Formoterol of and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050136009A1 (en) * 2003-10-20 2005-06-23 Schering Corporation Pharmaceutical compositions
EP1925293A3 (de) * 2003-10-20 2010-01-13 Schering Corporation Pharmazeutische Aerosol-Zusammensetzungen
EP1595531A1 (de) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
PL2077830T3 (pl) * 2006-10-17 2013-04-30 Lithera Inc Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
TWI695723B (zh) * 2009-05-29 2020-06-11 美商沛爾醫療股份有限公司 用於經由呼吸道輸送活性劑的組成物以及相關方法與系統
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
DK2482799T3 (da) * 2009-10-02 2014-09-01 Chiesi Farma Spa Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050905A1 (en) * 1989-02-23 1990-08-24 George R. Felt Therapeutic aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
JPH06508149A (ja) * 1991-06-10 1994-09-14 シェリング・コーポレーション クロロフルオロカーボン不含エーロゾル製剤
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
JP3280974B2 (ja) * 1991-12-12 2002-05-13 グラクソ、グループ、リミテッド 医 薬
DK0617610T3 (da) * 1991-12-18 1997-10-06 Minnesota Mining & Mfg Suspensionsaerosolformuleringer.
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
DE69730723D1 (de) 2004-10-21
JP2000513340A (ja) 2000-10-10
DK0934057T3 (da) 2005-01-24
CA2257841A1 (en) 1997-12-18
NO320403B1 (no) 2005-11-28
ZA974546B (en) 1998-11-23
JP5000793B2 (ja) 2012-08-15
AR009231A1 (es) 2000-04-12
NZ333202A (en) 2000-06-23
AU3373997A (en) 1998-01-07
WO1997047286A1 (en) 1997-12-18
DE69730723T2 (de) 2005-10-06
EP0934057B1 (de) 2004-09-15
EP0934057A1 (de) 1999-08-11
NO985720L (no) 1999-02-11
CA2257841C (en) 2008-05-20
EP1400239A1 (de) 2004-03-24
PT934057E (pt) 2004-12-31
NO985720D0 (no) 1998-12-07
AU726382B2 (en) 2000-11-02
ID19520A (id) 1998-07-16
ES2229366T3 (es) 2005-04-16
GB9612297D0 (en) 1996-08-14

Similar Documents

Publication Publication Date Title
ATE275940T1 (de) Medizinische aerosolformulierungen von formoterol
DE59505055D1 (de) Dermal applizierbare formulierungen von parasitiziden
ATE320246T1 (de) Medizinische aerosolformulierungen enthaltend budesonide
FI972657A0 (fi) Proteiinien ja peptidien aerosoliformuloinnit
ATE236617T1 (de) Aerosol-arzneiformulierungen
DE69503467D1 (de) Temporäre medizinische elektrode
DE69709366T2 (de) Medizinische klebende zusammensetzung und verpackung
DE69727329D1 (de) Medizinische Elektrode
DE69738755D1 (de) Sofort auflösbare medizinische zusammenstellung
DE59401563D1 (de) Medizinische Zange
DE69021387T3 (de) Medizinische aerosolformulierungen.
DE68904300D1 (de) Medizinische aerosolformulierungen.
ATE277615T1 (de) Therapeutische zusammensetzungen, enthaltend amlopidin und atorvastatin
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
FI965204A0 (fi) Bromelaiinin lääkekäyttö
ID18832A (id) Komposisi insektisida
ID21862A (id) Komposisi-komposisi insektisida dan mitisida
ID22534A (id) Komposisi-komposisi insektisida dan mitisida
ID17640A (id) Susunan pestisida
ID22068A (id) Komposisi-komposisi insektisida dan mitisida
FI963263A (fi) Bromelaiinin lääkinnällinen käyttö
ID22288A (id) Komposisi-komposisi insektisida dan mitisida
ID23774A (id) Komposisi insektisida
DE19581635T1 (de) Medizinische Elektrode
DE69602248T2 (de) 4a-aryldecahydroisochinolin-verbindungen und ihre medizinische verwendungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0934057

Country of ref document: EP

REN Ceased due to non-payment of the annual fee